Navigation Links
Funding for animal testing alternative
Date:8/23/2013

A researcher from Plymouth University Peninsula Schools of Medicine and Dentistry has received an award of 94,365 (Sterling) from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), for a pilot study to develop the lab-based creation of a type of mouse cell which could be used in place of the live animals for research related to infectious and allergic lung conditions.

Macrophages are crucial components of the immune system and play key roles in the body's defence against invading pathogens. Macrophages can be switched to perform different functions by chemical messengers produced by cells and tissues in response to infection. Some are switched to M2 macrophages which play a role in infections and allergic diseases such as asthma.

More needs to be understood about M2 macrophages if they are to play a part in effective therapies for infections. However, the cells acquired from live mice have a limited lifespan and require the repeated use of the animals.

Dr. Gyorgy Fejer will use the award to establish permanently growing, alternatively activated M2 macrophage cell lines in order to reduce the number of animals currently used to provide such cells for study. His work revolves around mouse lung macrophages which can be grown indefinitely and are available in practically unlimited numbers.

Compared with cell harvesting from a live mouse, the difference is striking: approximately 300,000 cells can be obtained from a mouse, whereas Dr. Fejer and his team can obtain 20-30 million cells from a single tissue culture flask.

This means that scientists who research asthma and pulmonary virus and bacterial infections can for the first time have access to almost limitless cells for study, without the need for live mice.

Dr. Fejer's award is one of several presented to scientists across the UK by NC3Rs for smart approaches to reduce animal use in science. It follows the publication by Dr. Fejer of related findings in the prestigious journal, PNAS Plus.


'/>"/>

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth
Source:Eurekalert

Related biology news :

1. Research!America says budget negotiations heighten urgency to protect research funding
2. Research!America says house funding levels for FY13 could undermine medical progress
3. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
4. University of Tennessee professor receives funding for clean coal research
5. House funding bill will delay research progress and place new burdens on NIH
6. Space research institute awards funding to promising medical products
7. University of Minnesota receives $13.1 million in DOE funding for 2 new nationwide centers
8. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
9. State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts
10. University spin-out company shares in £7.9 million marine energy funding boost
11. £12 million funding to tackle devastating livestock and poultry viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: